On Friday, Capricor Therapeutics Inc (NASDAQ: CAPR) opened higher 6.95% from the last session, before settling in for the closing price of $14.38. Price fluctuations for CAPR have ranged from $3.52 to $23.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 434.62% annually for the last half of the decade. Company’s average yearly earnings per share was noted -43.37% at the time writing. With a float of $39.98 million, this company’s outstanding shares have now reached $40.33 million.
In an organization with 102 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 95.71%, operating margin of -154.68%, and the pretax margin is -146.86%.
Capricor Therapeutics Inc (CAPR) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Capricor Therapeutics Inc is 12.08%, while institutional ownership is 39.05%. The most recent insider transaction that took place on Sep 20 ’24, was worth 14,999,998. In this transaction 10% Owner of this company bought 2,798,507 shares at a rate of $5.36, taking the stock ownership to the 7,090,351 shares.
Capricor Therapeutics Inc (CAPR) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -43.37% per share during the next fiscal year.
Capricor Therapeutics Inc (NASDAQ: CAPR) Trading Performance Indicators
Check out the current performance indicators for Capricor Therapeutics Inc (CAPR). In the past quarter, the stock posted a quick ratio of 4.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 30.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.06, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.98 in one year’s time.
Technical Analysis of Capricor Therapeutics Inc (CAPR)
Let’s dig in a bit further. During the last 5-days, its volume was 1.3 million. That was better than the volume of 0.95 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 38.50%. Additionally, its Average True Range was 1.17.
During the past 100 days, Capricor Therapeutics Inc’s (CAPR) raw stochastic average was set at 28.07%, which indicates a significant decrease from 66.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 85.84% in the past 14 days, which was lower than the 101.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.30, while its 200-day Moving Average is $10.91. However, in the short run, Capricor Therapeutics Inc’s stock first resistance to watch stands at $15.84. Second resistance stands at $16.31. The third major resistance level sits at $17.17. If the price goes on to break the first support level at $14.51, it is likely to go to the next support level at $13.65. The third support level lies at $13.18 if the price breaches the second support level.
Capricor Therapeutics Inc (NASDAQ: CAPR) Key Stats
There are currently 45,470K shares outstanding in the company with a market cap of 699.33 million. Presently, the company’s annual sales total 25,180 K according to its annual income of -22,290 K. Last quarter, the company’s sales amounted to 2,260 K and its income totaled -12,560 K.
